- Project status
- Project start date
- 12 Mar 2018
- Project posted
- 26 Feb 2018 17:51
- Project duration (approx.)
- 5.0 Days
- Budget (approx.)
- £8000 (fixed cost)
- Level of Experience
- Area of expertise
- Corporate Finance / M&A
- Consultant location
- United Kingdom
- English (Essential)
Objectives and Key Deliverables
We are a global management consulting firm and engaged by a private equity client evaluating a potential acquisition of a generic pharmaceuticals business.
As part of the due diligence process the client has asked us to review the regulatory operations of the target business.
The target business’ business plan includes:
- Re-transfer of production currently undertaken by CMOs/ the parent company into the production facilities of the target
- An increase in output and productivity in bringing new products to market/ delivering market authorisations
We are looking to engage with a professional with experience in the regulatory function of a major generics business and with experience dealing with regulators in particular the EMA (and the FDA). Ideally the professional would also have experience in M&A processes and evaluating the regulatory functions of target businesses.
The consultant will attend a site visit in Prague next week (Wednesday March 14), participate in a regulatory session and then produce a red flags report. The expected workload will be around 5 days. Therefore, we are looking for a consultant immediately.
The consultant will fly to Prague for the site visit (fly in Tuesday evening and fly out Wednesday evening). The rest of the work can be done remotely or in our London office. Travel & Expenses are covered.